• Blog
  • Chronic Low Back Pain Treatment Market Analysis | 2021-2026

    Chronic Low Back Pain Treatment Market Analysis | 2021-2026

    Chronic Low Back Pain Treatment Market Analysis | 2021-2026
    Report code - SRHL198 Delivery - 2 Weeks
    Chronic Low Back Pain Treatment Market Size, Share, Trends, Forecast & Competitive Ana See more...

    Market Insights

    The Chronic Low Back Pain Treatment Market is projected to grow from USD 7.35 billion in 2020 to USD 9.78 billion by 2026 at a CAGR of over 4.9% during the forecast period.

    Chronic-Low-Back-Pain-Treatment-Market-Forecast

    Wish to get a free sample? Register Here

    What is Chronic Low Back Pain?

    Chronic Low Back Pain (CLBP) is a persistent and often debilitating condition characterized by consistent discomfort or pain in the lower back region, typically lasting for more than 12 weeks. Unlike acute back pain, which may result from an injury or strain and usually resolves with time, CLBP persists and can significantly affect one's daily life and overall well-being.

    The causes of CLBP can vary, including factors like muscle or ligament injuries, degenerative disc disease, spinal stenosis, herniated discs, or underlying medical conditions. CLBP may lead to reduced mobility, and limitations in performing daily activities, and can have a profound impact on an individual's physical, emotional, and social health. Management and treatment options for CLBP range from physical therapy and medications to more invasive interventions, depending on the underlying cause and severity of the condition.

    Market Dynamics

    As per the National Institute of Neurological Disorders and Stroke, around 80 % of adults experience this form of low back pain at some phase in life.

    An upsurge in the occurrence of nerve cases and rising growth in the geriatric population are likely to augment the market growth. Moreover, growing healthcare awareness among developed and emerging countries, inactive lifestyles, and growing purchasing power of consumers promulgates the demand for chronic low back pain treatment. However, the unavailability of proper medication and poor supply chain management are some of the restraining negatively affecting the market expansion.

    COVID-19 Impact

    The outbreak of the COVID-19 pandemic has adversely impacted the chronic low back pain treatment industry due to postponed appointments and strict social distance norms resulting in fewer treatment appointments. However, due to work from work-from-home policy, employees are suffering from severe lower back pain due to poor sitting posture and the absence of work furniture in many countries across the globe.

    Segments Analysis

    Treatment Type Trends

    By treatment type, the chronic low back pain treatment market has been segmented into analgesic medication, nonsteroidal anti-inflammatory drugs, anticonvulsants, antidepressants, and others.

    • Under these, the analgesic medication segment dominated the market and is projected to register a healthy CAGR during the assessment period.

    • Analgesics are mainly developed to relieve pain.

    • These medications consist of prescription opioids such as morphine, hydrocodone, oxycodone, and codeine as well as OTC aspirin and acetaminophen.

    • The need to reduce lower back pain drives the demand for analgesics.

    Regional Analysis

    By region, the North American market accounted for the largest market share and is projected to grow at a steady CAGR during the forecast period.

    • This is mainly attributed to the growing awareness among the people regarding chronic lower back pain, high per capita income, rising prevalence of chronic lower back pain, and increasing emphasis on the prevention of chronic lower back pain, thus augmenting the regional market growth.

    • Also, the highest diagnosed prevalence of chronic low back pain is in the U.S. with over 20 million cases in 2017.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    Key players operating in the global chronic low back pain treatment market are-

    • Johnson & Johnson Services Inc. (The U.S.),
    • Pfizer Inc. (The U.S.),
    • Sanofi (France),
    • Endo Pharmaceuticals Inc. (Ireland),
    • Merck & Co., Inc. (The U.S.),
    • Vertebral Technologies, Inc. (The U.S.),
    • Medtronic (Ireland),
    • Boston Scientific Corporation (The U.S.),
    • Braeburn Pharmaceuticals (The U.S.), and
    • Camurus (Sweden).

    Target Audience

    The following is a list of the customers that the Chronic Low Back Pain Market aims to convert the most:

    • Chronic low back pain treatment companies
    • Hospitals
    • R&D centers
    • Pharmaceutical companies
    • Orthopedic Clinics

    Critical Questions Answered in the Report

    • What are the key trends in the global chronic low back pain treatment market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global chronic low back pain treatment market?
    • What are the key strategies adopted by the major vendors to lead in the global chronic low back pain treatment market?
    • What is the market share of the top vendors?

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Chronic Low Back Pain Treatment Market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Who are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players).
    • SWOT analysis of key players (up to three players).

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@Stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The Global Chronic Low Back Pain Treatment Market is projected to grow at a CAGR of over 4.9% during the forecast period.

    Johnson & Johnson Services Inc. (The U.S.), Pfizer Inc. (The U.S.), Sanofi (France), Endo Pharmaceuticals Inc. (Ireland), Merck & Co., Inc. (The U.S.), Vertebral Technologies, Inc. (The U.S.), Medtronic (Ireland), Boston Scientific Corporation (The U.S.), Braeburn Pharmaceuticals (The U.S.), and Camurus (Sweden) are among the key players in the chronic low back pain treatment market.

    The Global Chronic Low Back Pain Treatment Market is projected to grow from USD 7.35 billion in 2020 to USD 9.78 billion by 2026 during the forecast period.

    North American market accounted for the largest market share and is projected to grow at a steady CAGR during the forecast period.

    An upsurge in the occurrence of nerve cases, rising growth in the geriatric population, growing healthcare awareness among developed and emerging countries, inactive lifestyles, and growing purchasing power of consumers are the factors driving the growth of the chronic low back pain treatment market.

    The analgesic medication segment dominated the market and is projected to register a healthy CAGR during the assessment period.

    Chronic low back pain treatment companies, Hospitals, R&D centers, pharmaceutical companies, and Orthopedic Clinics are the target audience in the chronic low back pain treatment market.